PFE Financial Facts
Less: Net income attributable to noncontrolling interests: 0Net income attributable to Pfizer Inc.: 1.32B
See Full Income Statement
Equity attributable to noncontrolling interests: 294M
Retained earnings: 72.85B
See Full Balance Sheet
Pfizer Inc. (PFE) Earnings
|
Expand Research on PFE
Next EPS Date | 5/1/24 | EPS Growth Rate | -58.5% |
---|---|---|---|
Average EPS % Beat Rate | +21.5% | Revenue Growth Rate | -23.7% |
Average % Move 1-Wk after EPS | -0.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
11/2/21 | Q321 | $1.37 | $1.08 | +$0.29 | $24.1B | $22.68B | Details | ||||
7/31/18 | Q218 | $0.81 | $0.74 | +$0.07 | $13.47B | $13.31B | = | Details | |||
7/28/21 | Q221 | $1.07 | $0.96 | +$0.11 | $19B | $18.45B | Details | ||||
11/1/22 | Q322 | $1.78 | $1.44 | +$0.34 | $22.6B | $21.33B | = | Details | |||
7/28/15 | Q215 | $0.56 | $0.52 | +$0.04 | $11B | $11.42B | Details | ||||
1/29/19 | Q418 | $0.64 | $0.63 | +$0.01 | $13.98B | $13.91B | Details | ||||
5/3/16 | Q116 | $0.67 | $0.55 | +$0.12 | $13B | $12B | Details | ||||
10/27/15 | Q315 | $0.60 | $0.51 | +$0.09 | $12.1B | $11.56B | Details |